Sanofi claims that Mylan offered 'unprecedented rebates' on EpiPens to prevent uptake of its Auvi-Q

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.